CIBC Bancorp USA’s Cardinal Health CAH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$127M Sell
535,711
-349,644
-39% -$72.7M 0.15% 145
2026
Q1
$187M Buy
+885,355
New +$191M 0.25% 103
2025
Q3
$6.06M Buy
+38,620
New +$5.97M 0.03% 365

Other funds holding CAH

CIBC Bancorp USA's CAH Position: Q2 2026 in Review

CIBC Bancorp USA reduced its Cardinal Health (CAH) stake by 39% in Q2 2026, selling an estimated $72.7M and leaving 535,711 shares worth $127M. The position accounts for 0.15% of the portfolio, ranked #145.

CIBC Bancorp USA first reported a position in CAH in Q3 2025 and has held it in 3 quarters since. The position peaked at $187M in Q1 2026. 1,501 funds tracked by Wall St. Rank hold CAH as of Q2 2026.

  • CIBC Bancorp USA held 535,711 shares of Cardinal Health worth $127M as of Q2 2026.
  • CIBC Bancorp USA sold 349,644 Cardinal Health shares in Q2 2026, an estimated $72.7M.
  • Cardinal Health made up 0.15% of CIBC Bancorp USA's portfolio in Q2 2026, its #145 holding.
  • CIBC Bancorp USA first reported a position in Cardinal Health in Q3 2025 and has held it in 3 quarters since.
  • CIBC Bancorp USA's Cardinal Health position peaked at $187M in Q1 2026.
  • 1,501 funds tracked by Wall St. Rank held Cardinal Health as of Q2 2026.

Based on CIBC Bancorp USA's 13F filing for Q2 2026, filed 13 Aug 2026.